Intellia Therapeutics (NTLA): Rasio rega marang bathi tumrap wutah
Intellia Therapeutics (NTLA) outsources its drug production, relying on external contractors. The level of undervaluation based on the PEG ratio is clearly demonstrated by the current trend, where the value of 0.00 expresses the metric's level. Meanwhile, the patent protection of CRISPR therapy creates a significant market barrier, and strategic scientific alliances with biotech partners accelerate the development of innovative treatments for genetic pathologies.
Intellia Therapeutics (NTLA) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Intellia Therapeutics|NTLA - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal intelliatx.com|NTLA - Gunggung utang perusahaan|Utang marang modal buku Intellia|NTLA - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Intellia Therapeutics|Likuiditas darurat intelliatx.com
- rincian asil keuangan lan kelipatan valuasi:
NTLA - Bathi resik perusahaan|Penghasilan resik sing dikarepake Intellia Therapeutics|NTLA - Pangali P/E|Pangali Forward P/E Intellia Corp|NTLA - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Intellia|NTLA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Intellia Therapeutics|NTLA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan intelliatx.com|NTLA - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Intellia Therapeutics
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:Intellia Therapeutics Inc
The PEG ratio compares the P/E multiple with earnings growth rates, determining whether the current share price is justified by the business's growth dynamics. For Intellia Therapeutics (NTLA), which develops CRISPR technologies, this growth company undervaluation metric helps assess the efficiency of investments in proprietary genome editing platforms relative to their capitalization potential.
Perusahaan pesaing
TEM - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Qiagen Group QGEN|Isis Pharmaceuticals - Rasio rega marang bathi tumrap wutah|RGEN - Rasio rega marang bathi tumrap wutah|RNA: Rasio rega marang bathi tumrap wutah|CRSP: Pangali PEG|WGS - Kapitalisasi marang bathi resik kanthi nimbang wutah|RARE (Ultragenyx Pharma) - Pangali PEG|Pangali PEG Beam Tx|Pangali rega marang bathi tumrap wutah SRPT (Sarepta Therapeutics, Inc.)|TWST (twistbioscience.com) - Koefisien bali modal nimbang wutah|10x Genomics - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi STOK (Stoke Therapeutics Inc)|BioLife Corp - Pangali PEG|Koefisien bali modal nimbang wutah WVE (Wave Pharma)|MAZE: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah sionnatx.com (SION)|Rasio rega marang bathi tumrap wutah Prime Medicine|TSHA: Koefisien bali modal nimbang wutah|Pangali PEG QURE|Pangali PEG MeiraGTx Corp (MGTX)|Rasio rega marang bathi tumrap wutah REGENXBIO Inc. RGNX|SLDB (solidbio.com) - Rasio kapitalisasi marang bathi lan wutah|Ocugen - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Pacific Biosciences of California, Inc.|BNTC (Benitec) - Pangali rega marang bathi tumrap wutah|Design Corp (DSGN) - Pangali PEG|Pangali rega marang bathi tumrap wutah RCKT|FDMT (4dmoleculartherapeutics.com) - Rasio nilai perusahaan marang wutah bathi|Pangali PEG LXEO|Kapitalisasi marang bathi resik kanthi nimbang wutah korrobio.com|Pangali PEG EDIT (Editas)|SLN - Pangali rega marang bathi tumrap wutah|PRQR - Rasio rega marang bathi tumrap wutah|Kapitalisasi marang bathi resik kanthi nimbang wutah Codexis, Inc. CDXS|Sangamo Therapeutics, Inc. (SGMO) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah NAUT|Pangali rega marang bathi tumrap wutah MGX|DTIL (Precision BioSciences Inc.) - Rasio nilai perusahaan marang wutah bathi|Rasio rega marang bathi tumrap wutah Generation Bio Co. (GBIO)|Rasio rega marang bathi tumrap wutah BOLD (boundlessbio.com)|Pangali PEG XCUR (Exicure)|Pangali PEG Imunon Inc IMNN|RXi Pharmaceuticals - Pangali PEG|MBIO (Mustang Bio, Inc.) - Rasio P/E diaturake wutah|transcodetherapeutics.com (RNAZ) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah BNGO|APDN (Applied DNA Sciences, Inc.) - Pangali PEG|Pangali PEG bluebird bio Inc.|Pangali PEG IPA|Kapitalisasi marang bathi resik kanthi nimbang wutah Omega Therapeutics Corp|Rasio rega marang bathi tumrap wutah Singular Genomics Systems OMIC|RGLS: Rasio P/E diaturake wutah|SYRS: Pangali rega marang bathi tumrap wutah|Telesis Bio Inc. - Rasio nilai perusahaan marang wutah bathi|TCON: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Unity Biotechnology, Inc (UBX)
